Literature DB >> 23474302

The influence of influenza virus infections on the development of tuberculosis.

Roelof A de Paus1, Reinout van Crevel, Ruud van Beek, Edhyana Sahiratmadja, Bachti Alisjahbana, Sangkot Marzuki, Guus F Rimmelzwaan, Jaap T van Dissel, Tom H M Ottenhoff, Esther van de Vosse.   

Abstract

Recently, it was shown that interferon-γ mediated immune responses, which play a major role in the control of infection with Mycobacterium tuberculosis (Mtb), can be inhibited by type I interferons. Since type I interferons are abundantly induced during viral infections, we hypothesized that infections with influenza viruses might play a role in the development of active TB disease either directly after exposure to Mtb or through reactivation of latent Mtb infection. To explore this hypothesis we investigated in a retrospective study whether newly diagnosed adult tuberculosis patients from Indonesia had had recent influenza infection. Plasma samples from TB patients and controls were assayed for antibodies against two subtypes of at that time relevant, seasonal influenza A viruses. Overall, no correlation was observed with the presence of antibodies and manifest tuberculosis. Still, antibody titers against circulating A/H3N2 influenza virus were slightly enhanced in tuberculosis patients as compared to controls, and highest in cases of advanced tuberculosis. This suggests that tuberculosis patients were recently infected with influenza, before clinical manifestation of the disease. Alternatively, the production of antibodies and susceptibility to tuberculosis may be influenced by a common confounding factor, for example the ability of patients to induce interferon-α. We conclude that in an endemic country like Indonesia, an influenza virus infection is not a major determinant for developing clinically manifest tuberculosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474302     DOI: 10.1016/j.tube.2013.02.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

Review 1.  Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases.

Authors:  Matthew Bates; Ben J Marais; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

2.  Respiratory microbes present in the nasopharynx of children hospitalised with suspected pulmonary tuberculosis in Cape Town, South Africa.

Authors:  Felix S Dube; Mamadou Kaba; F J Lourens Robberts; Lemese Ah Tow; Sugnet Lubbe; Heather J Zar; Mark P Nicol
Journal:  BMC Infect Dis       Date:  2016-10-24       Impact factor: 3.090

3.  The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010-2016.

Authors:  Sibongile Walaza; Stefano Tempia; Halima Dawood; Ebrahim Variava; Nicole Wolter; Andries Dreyer; Jocelyn Moyes; Claire Von Mollendorf; Meredith McMorrow; Anne Von Gottberg; Sumayya Haffejee; Marietje Venter; Florette K Treurnicht; Orienka Hellferscee; Neil A Martinson; Nazir Ismail; Cheryl Cohen
Journal:  Open Forum Infect Dis       Date:  2019-03-19       Impact factor: 3.835

Review 4.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

5.  Influenza and tuberculosis co-infection: A systematic review.

Authors:  Sibongile Walaza; Cheryl Cohen; Stefano Tempia; Jocelyn Moyes; Athermon Nguweneza; Shabir A Madhi; Meredith McMorrow; Adam L Cohen
Journal:  Influenza Other Respir Viruses       Date:  2019-09-30       Impact factor: 4.380

Review 6.  Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).

Authors:  Catherine Wei Min Ong; Giovanni Battista Migliori; Mario Raviglione; Gavin MacGregor-Skinner; Giovanni Sotgiu; Jan-Willem Alffenaar; Simon Tiberi; Cornelia Adlhoch; Tonino Alonzi; Sophia Archuleta; Sergio Brusin; Emmanuelle Cambau; Maria Rosaria Capobianchi; Concetta Castilletti; Rosella Centis; Daniela M Cirillo; Lia D'Ambrosio; Giovanni Delogu; Susanna M R Esposito; Jose Figueroa; Jon S Friedland; Benjamin Choon Heng Ho; Giuseppe Ippolito; Mateja Jankovic; Hannah Yejin Kim; Senia Rosales Klintz; Csaba Ködmön; Eleonora Lalle; Yee Sin Leo; Chi-Chiu Leung; Anne-Grete Märtson; Mario Giovanni Melazzini; Saeid Najafi Fard; Pasi Penttinen; Linda Petrone; Elisa Petruccioli; Emanuele Pontali; Laura Saderi; Miguel Santin; Antonio Spanevello; Reinout van Crevel; Marieke J van der Werf; Dina Visca; Miguel Viveiros; Jean-Pierre Zellweger; Alimuddin Zumla; Delia Goletti
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

Review 7.  TB vaccine development and the End TB Strategy: importance and current status.

Authors:  Helen A Fletcher; Lewis Schrager
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-04       Impact factor: 2.184

8.  Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: a cohort study.

Authors:  F Mhimbira; H Hiza; E Mbuba; J Hella; L Kamwela; M Sasamalo; M Ticlla; K Said; G Mhalu; M Chiryamkubi; C Schindler; K Reither; S Gagneux; L Fenner
Journal:  Clin Microbiol Infect       Date:  2018-03-23       Impact factor: 8.067

Review 9.  TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.

Authors:  Erica Luke; Kimberly Swafford; Gabriella Shirazi; Vishwanath Venketaraman
Journal:  Front Biosci (Schol Ed)       Date:  2022-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.